Additional information Active substance Liraglutide Chemical name Liraglutide Side effects Nausea, diarrhea, vomiting, constipation, reduced appetite, risk of pancreatitis Effects Improves glycemic control in type 2 diabetes, promotes weight loss Dosage (sports) Not applicable Dosage (medical) Typically initiated at 0.6 mg per day, titrated up to 1.2 mg or 1.8 mg depending on the patient's response and tolerability Half-life Approximately 13 hours Main action Lowers blood glucose levels Substance class Glucagon-like peptide-1 (GLP-1) receptor agonist Formula C172H265N43O51 Storage conditions Store in a refrigerator (2В°C to 8В°C), protect from light, do not freeze FORM 1 pen x 3 ml Trade name Victoza, Saxenda Blood pressure May help reduce blood pressure in patients with type 2 diabetes Also known as NN2211 Lab Test Monitoring of blood glucose and hemoglobin A1c levels Hepatotoxicity Low Water Retention Minimal Dosage 0.6-1.8 mg/day Active Half-Life Peptide Use in sports Not typically used for performance enhancement Manufacturer Novo Nordisk
